# Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease

Study · id `cardio:ct-nct02579889` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02579889](<https://clinicaltrials.gov/study/NCT02579889>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02579889

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1390 participants.

## Technical summary

Registry record NCT02579889. Randomized; single masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2023-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1390 participants (enrolled count; ClinicalTrials.gov record NCT02579889, source copy `cardio:ctgov-nct02579889-2024-01-18`, retrieved 2026-10-26)
- Start date: 2015-09 (registry gives no type) (ClinicalTrials.gov record NCT02579889, source copy `cardio:ctgov-nct02579889-2024-01-18`, retrieved 2026-10-26)
- Primary completion: 2023-03 (actual) (ClinicalTrials.gov record NCT02579889, source copy `cardio:ctgov-nct02579889-2024-01-18`, retrieved 2026-10-26)
- Completion: 2023-12 (actual) (ClinicalTrials.gov record NCT02579889, source copy `cardio:ctgov-nct02579889-2024-01-18`, retrieved 2026-10-26)
- Countries: China; Hungary; India; Italy; Malaysia; Singapore; South Korea; Spain; Taiwan (ClinicalTrials.gov record NCT02579889, source copy `cardio:ctgov-nct02579889-2024-01-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02579889-2024-01-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease
- Acronym: B3
- Condition: Sinus Node Disease
- Intervention (Device): DDD+CLS
- Intervention (Device): DDD(R)
- Lead sponsor: Biotronik SE & Co. KG
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Sick sinus syndrome (`cardio:sick-sinus-syndrome`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Biotronik SE & Co. KG (`cardio:org-biotronik-se-co-kg`)

## Provenance

Content hash: ea7b8dda2d2947be835bce1dd2d4f952b9ef0354d0c9e9008d181051a7375a4c
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
